Results 21 to 30 of about 18,591,271 (238)
Metabolism of New Psychoactive Substances 4F-MDMB-BUTINACA in Zebrafish [PDF]
Fayixue Zazhi, 2021 Objective To study the metabolic transformation pathways of 4F-MDMB-BUTINACA in vivo by establishing zebrafish models. Methods Six adult zebrafish were randomly divided into blank control group and experimental group, with three fish in each group. After
YUE Lin-na, XIANG Ping, SONG Fen-yun, et al.
doaj +1 more source
Journal of Geography, Politics and Society, 2019 The main objective of the paper is to explain, compare and conclude the effect on the new psychoactive substances (NPS) market brought by new and innovative responses to regulate the NPS (mostly between 2010 and 2014) in Estonia, Latvia, Lithuania ...
Artur Malczewski +1 more
doaj +1 more source
International Journal of Occupational Medicine and Environmental Health, 2020 Objectives This study analyzed the prevalence of new psychoactive substance (NPS) use in the analyzed group and compared demographic features and psychoactive substance profiles between the 2 subgroups (NPS users, non-NPS users).
Piotr Engelgardt +5 more
doaj +1 more source
Indian Journal of Psychiatric Nursing, 2022 In recent years, new psychoactive substances (NPS) (”legal highs” or “designer drugs”) are increasing worldwide. An increase in NPS is a cause for concern for drug-regulatory authorities and health-care professionals as it poses a threat to public health.
Raka Jain, Kamini Verma
doaj +1 more source
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling [PDF]
, 2015 Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as
Liechti, Matthias E., Matthias Liechti
core +1 more source
Pharmacology of novel psychoactive substances [PDF]
, 2016 This PhD work consists of an in vitro and in vivo part. In the in vivo part, we investigated the role of dopamine in the acute clinical effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in healthy human subjects.
Rickli, Anna
core +1 more source
Head shops and new psychoactive substances: a public health perspective.
, 2023 In 2010, Ireland found itself at the eye of an international storm as a network of head shops emerged selling new psychoactive substances (NPS) and Irish youth rapidly became the heaviest users of NPS in Europe.
Smyth, Bobby P
core +1 more source
Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones
Biomedicines, 2022 In the recent decade, numerous new psychoactive substances (NPSs) have been added to the illicit drug market. These are synthetized to mimic the effects of classic drugs of abuse (i.e., cannabis, cocaine, etc.), with the purpose of bypassing substance ...
Leila Mazdai +11 more
doaj +1 more source
Legal approaches to new psychoactive substances: first empirical findings.
, 2023 BACKGROUND: Generic drug legislation, i.e., simultaneously banning groups of drugs, has been introduced worldwide to counteract the trade and use of emerging "new psychoactive substances" (NPSs) more effectively.
van Amsterdam, Jan +2 more
core +1 more source
New psychoactive substances: Issues and challenges
Journal of Mental Health and Human Behaviour, 2016 New psychoactive substances (NPS) have emerged as "legal" alternatives to internationally controlled drugs and commonly known by terms such as "designer drugs," "legal highs," or "herbal highs." These drugs are gaining popularity among youth in recent ...
Vaibhav Patil +2 more
doaj +1 more source